GO:0005179 hormone activity: Mechanism, Genes

Hormone activity (GO:0005179) is a molecular function term that captures the action characteristic of a hormone: any substance formed in very small amounts in one specialized organ or group of cells and carried, sometimes in the bloodstream, to another organ or group of cells in the same organism, upon which it has a specific regulatory action. This definition encompasses classical endocrine hormones as well as regulatory compounds in lower animals and plants, and synthetic substances with comparable effects, all of which bind receptors and trigger a biological process. Understanding hormone activity is fundamental to endocrinology, metabolism, and exercise physiology, because hormones coordinate systemic responses such as growth, energy balance, and cognitive function. Research into hormone activity has expanded beyond classical endocrine glands to include exercise-induced myokines and adipokines, such as irisin, which is cleaved from FNDC5 and released into circulation to regulate brown-fat-like development and cognition. Physical activity modulates a broad spectrum of hormone responses, including growth hormone, testosterone, insulin-like growth factors, and cortisol, which together integrate cellular development and growth. These findings underscore that hormone activity is not a static property but a dynamic, context-dependent function influenced by physiological state. For researchers, GO:0005179 provides a standardized framework to annotate gene products that function as hormones, enabling comparative genomics, functional enrichment, and systems-level analysis of endocrine signaling. Because hormone activity is implicated in sarcopenia, overtraining syndrome, and metabolic disease, precise experimental models are needed to establish causality between specific hormone genes and physiological outcomes. This article reviews the definition, mechanisms, key genes, disease links, and CRISPR-based research methods relevant to GO:0005179.

In our own words, GO:0005179 hormone activity is the molecular function of a substance that is produced in very small quantities by a specialized organ or cell group, is transported (sometimes via the bloodstream) to a distinct target organ or cell group within the same organism, and there exerts a specific regulatory action by binding to receptors and triggering a biological process. The term was originally applied to agents with stimulatory physiological actions in vertebrates, as opposed to chalones with depressant actions, but its usage now extends to regulatory compounds in lower animals and plants and to synthetic substances with comparable effects. Synonyms include cAMP generating peptide activity, glycopeptide hormone, lipopeptide hormone, and peptide hormone.

Hormone activity is important because it governs systemic physiological regulation, including growth, metabolism, reproduction, stress responses, and cognitive function, through precise receptor-mediated signaling. Exercise and physical activity dynamically modulate hormone responses, and dysregulation of these responses is linked to conditions such as overtraining syndrome and sarcopenia. Because hormones act at very low concentrations and often at distant sites, understanding their activity requires integrated experimental approaches that connect molecular function to organismal physiology.

The following genes encode hormones or hormone-related proteins that exemplify GO:0005179 hormone activity and are widely studied in endocrine, metabolic, and exercise research.

Hormone activity is regulated at multiple levels, including synthesis, secretion, transport, receptor availability, and feedback loops. Exercise and physical activity modulate hormone responses, altering circulating levels of growth hormone, testosterone, IGFs, and cortisol. Feedback regulation by target-tissue signals maintains homeostasis, and disruption of these loops can lead to pathological states such as overtraining syndrome. Additionally, hormone activity can be influenced by nutritional status, circadian rhythms, and aging, as seen in sarcopenia.

Sarcopenia, the age-related loss of muscle mass and strength, is associated with altered hormone activity, including changes in growth hormone, IGF1, and testosterone signaling. These hormonal shifts contribute to reduced muscle protein synthesis and impaired regeneration, making hormone activity a therapeutic target for preserving muscle function in aging populations. Research models that manipulate hormone genes can help establish causality between specific hormones and sarcopenia phenotypes.

Overtraining syndrome is characterized by maladaptive endocrine responses, including disrupted cortisol, testosterone, and growth hormone activity, which can impair performance and recovery. The joint consensus statement on overtraining syndrome highlights the importance of hormonal assessment in diagnosis and prevention. Studying hormone activity in exercise models can reveal mechanisms underlying this condition and inform treatment strategies.

Exercise hormone irisin, encoded by FNDC5, is a critical regulator of cognitive function, demonstrating that hormone activity extends to the central nervous system. Irisin released during exercise can cross into the brain and influence neuronal function, linking peripheral hormone activity to cognition. This has implications for neurodegenerative conditions and cognitive decline, where exercise-induced hormone activity may be protective.

Dysregulated hormone activity underlies metabolic disorders such as insulin resistance and obesity, where hormones including insulin, leptin, and adiponectin play central roles. Growth hormone, testosterone, IGFs, and cortisol also integrate metabolic and growth signals, and their imbalance can contribute to disease. Targeting hormone activity through lifestyle or pharmacological interventions is a major therapeutic avenue.

RNA-seq and proteomics can quantify expression of hormone-encoding genes and their downstream targets, providing a systems-level view of hormone activity. These methods are useful for identifying hormone-responsive gene networks in tissues such as muscle, adipose, and brain.

ELISA, radioimmunoassay, and mass spectrometry can measure hormone concentrations in blood or culture media, enabling assessment of secretion dynamics. Such assays are essential for validating CRISPR models of hormone genes.

Receptor binding assays, cAMP measurements, and kinase activity assays can determine whether a candidate hormone triggers receptor-mediated signaling, the defining feature of GO:0005179. These assays link molecular function to downstream biological processes.

Exercise tests, metabolic cages, and cognitive behavioral tests can assess the physiological impact of hormone activity in animal models. Combining these with genetic manipulation provides causal evidence for hormone function.

Researchers studying hormone activity-related genes often need to determine whether a candidate gene is causally involved in endocrine regulation, metabolism, or cognition. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell and animal models for GO:0005179 research.

GO:0005179 hormone activity defines a fundamental molecular function that connects endocrine signaling to organismal physiology, from metabolism and growth to cognition and exercise adaptation. Dysregulation of hormone activity underlies sarcopenia, overtraining syndrome, and metabolic disease, underscoring its clinical relevance. CRISPR-based models provide powerful tools to dissect the causal roles of hormone genes and to develop targeted interventions.